SPRO
Spero Therapeutics, Inc. · Healthcare
Chief Medical Officer Kamal Hamed sold $38K of Spero Therapeutics, Inc.
Sold$38,463
$1.37Price
28,075Shares
−3%Stake
What SPRO did after the filing
- The stock from Mon, Feb 5 close, $1.44
- +23.6%
- S&P 500, same days
- +5.0%
Measured over 30 trading days, to the Mar 19 close.
Traded Fri, Feb 2. Filed Mon, Feb 5, 3:45 PM ET, during the session. Returns use the Feb 5 close and the Mar 19 close. Not investment advice.